feed,title,long_url,short_url
Benzinga,BridgeBio Locks $2B Infigratinib Global Partnership For Oncology Indications,https://benzinga.com/general/biotech/21/03/20426548/bridgebio-locks-2b-infigratinib-global-partnership-for-oncology-indications,https://j.mp/3sDXwcV
